Tranexamic Acid in Gender Mastectomy

• Status: Suspended
• Trial end date: 2022-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

The goal of this study is to examine the use of tranexamic acid (TXA) in gender mastectomy surgery, specifically looking at volume loss (blood and transudate) postoperatively.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Wisconsin, Madison
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Undergoing gender mastectomy

• English speaking

Exclusion Criteria:

• History of thrombotic event (ie deep vein thrombosis, pulmonary embolism, stroke, myocardial infarction)

• genetic disorder that increases risk of thrombosis

• use of estrogens at time of surgery

• pregnancy